Showing results (751-760 of 822) with videos related to

Sort By:
Pageof 83
HIV Medicine|May 11, 2026
CHildren of the Cohort Study (CHOC): Exploring parenting desire among people living with HIV in SwitzerlandClara Merlin, José Damas, Olivier Nawej Tshikung, et al.
Plos Neglected Tropical Diseases|March 2, 2017
Human cystic echinococcosis in Morocco: Ultrasound screening in the Mid Atlas through an Italian-Moroccan partnershipHouda Chebli, Abderrhamane Laamrani El Idrissi, Mustapha Benazzouz, et al.
Royal Society Open Science|July 7, 2023
Sex and gender in infection and immunity: addressing the bottlenecks from basic science to public health and clinical applicationsChloé Pasin, Camila R Consiglio, Jana S Huisman, et al.
Transplantation and Cellular Therapy|January 29, 2022
Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell TransplantationAlice Huang, Caroline Cicin-Sain, Chloe Pasin, et al.
Frontiers in Veterinary Science|March 22, 2017
Toward Elimination of Dog-Mediated Human Rabies: Experiences from Implementing a Large-scale Demonstration Project in Southern TanzaniaEmmanuel Abraham Mpolya, Tiziana Lembo, Kennedy Lushasi, et al.
European Journal of Preventive Cardiology|April 27, 2026
Climate Change and Cardiovascular Risk Factors Management: Emerging Challenges and Strategies for Prevention and AdaptationMaria Marketou, Norma Caples, Mark D' Abela, et al.
British Journal of Haematology|November 16, 2022
Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantationAndriyana K Bankova, Chloé Pasin, Alice Huang, et al.
AIDS (London, England)|July 25, 2022
Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIVFrédérique Chammartin, Katharina Kusejko, Chloé Pasin, et al.
NPJ Vaccines|September 30, 2023
Assessing immunogenicity barriers of the HIV-1 envelope trimerLiridona Maliqi, Nikolas Friedrich, Matthias Glögl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2022
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled TrialBenjamin Speich, Frédérique Chammartin, Irene A Abela, et al.
Pageof 83